[HTML][HTML] A highly specific and sensitive serological assay detects SARS-CoV-2 antibody levels in COVID-19 patients that correlate with neutralization

…, M Deichner, F Hanses, M Lubnow, T Müller, D Lunz… - Infection, 2021 - Springer
Objective The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic
challenges national health systems and the global economy. Monitoring of infection rates and …

[HTML][HTML] Technical complications during veno-venous extracorporeal membrane oxygenation and their relevance predicting a system-exchange–retrospective …

M Lubnow, A Philipp, M Foltan, T Bull Enger, D Lunz… - PloS one, 2014 - journals.plos.org
Objectives Technical complications are a known hazard in veno-venous extracorporeal
membrane oxygenation (vvECMO). Identifying these complications and predictive factors …

Cardiac decompression on extracorporeal life support: a review and discussion of the literature

…, S Schopka, C Schmid, A Philipp, D Lunz… - Asaio …, 2013 - journals.lww.com
Extracorporeal life support is a worldwide expanding technology for patients in critical
cardiogenic shock. The device is usually attached to the femoral vessels using percutaneous …

Extracorporeal membrane oxygenation for refractory cardiac arrest: a retrospective multicenter study

D Lunz, L Calabrò, M Belliato, E Contri… - Intensive Care …, 2020 - Springer
Purpose The aim of this study was to assess the neurologic outcome following extracorporeal
cardiopulmonary resuscitation (ECPR) in five European centers. Methods Retrospective …

Hemostatic changes during extracorporeal membrane oxygenation: a prospective randomized clinical trial comparing three different extracorporeal membrane …

…, F Zeman, TB Enger, T Bein, D Lunz… - Critical care …, 2016 - journals.lww.com
Objective: Extracorporeal membrane oxygenation is a rescue therapy for patients with severe
lung failure. Major complications caused by extracorporeal membrane oxygenation are …

[HTML][HTML] Technical-induced hemolysis in patients with respiratory failure supported with veno-venous ECMO–prevalence and risk factors

K Lehle, A Philipp, F Zeman, D Lunz, M Lubnow… - PloS one, 2015 - journals.plos.org
The aim of the study was to explore the prevalence and risk factors for technical-induced
hemolysis in adults supported with veno-venous extracorporeal membrane oxygenation (…

[HTML][HTML] Argatroban versus heparin in patients without heparin-induced thrombocytopenia during venovenous extracorporeal membrane oxygenation: a propensity …

…, MV Malfertheiner, A Philipp, M Foltan, D Lunz… - Critical Care, 2021 - Springer
Background During venovenous extracorporeal membrane oxygenation (vvECMO), direct
thrombin inhibitors are considered by some potentially advantageous over unfractionated …

ECMO in COVID-19—prolonged therapy needed? A retrospective analysis of outcome and prognostic factors

…, C Fisser, M Foltan, F Geismann, B Graf, D Lunz… - …, 2021 - journals.sagepub.com
Background: The role of venovenous extracorporeal membrane oxygenation (VV ECMO) in
patients with COVID-19-induced acute respiratory distress syndrome (ARDS) still remains …

First experience with the ultra compact mobile extracorporeal membrane oxygenation system Cardiohelp in interhospital transport

A Philipp, M Arlt, M Amann, D Lunz… - … and thoracic surgery, 2011 - academic.oup.com
In patients with severe cardiopulmonary failure extracorporeal assist devices are to support
patients during resuscitation, for transportation, until organ recovery, and as bridge to further …

[HTML][HTML] Metabolic imbalance of T cells in COVID-19 is hallmarked by basigin and mitigated by dexamethasone

…, J Jantsch, C Brochhausen, D Lunz… - The Journal of …, 2021 - Am Soc Clin Investig
Metabolic pathways regulate immune responses and disrupted metabolism leads to immune
dysfunction and disease. Coronavirus disease 2019 (COVID-19) is driven by imbalanced …